FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

Sodium Bicarbonate Injection, USP
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Reverified 03/30/2020)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1) Intermittent supply IMS is releasing product, but market demand continues to exceed our capacity Demand increase for the drug

Exela Pharma Sciences, LLC (Revised 12/13/2019)

Company Contact Information:
828-758-5474 ext. 154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate Inj. USP, 8.4%, 50mL (NDC 51754-5001-1) Available direct or through Premier's ProvideGx program at this time and through CIVICA Rx program in Q1 2020. Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 03/24/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05) Available Check wholesalers for inventory Demand increase for the drug
8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL) (84 mg per mL)(NDC 63323-089-50) Available Check wholesalers for inventory Demand increase for the drug

Hospira, Inc. (Reverified 03/25/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Neut (Sodium Bicarbonate Additive Solution); 200 mg/5 mL (4%); Single Dose Glass Fliptop Vial (NDC 0409-6609-02) Discontinued Discontinuation of the manufacture of the drug
Infant; 5 mEq/10 mL (4.2%; 0.5 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-5534-34) Limited Supply Available. Next Delivery: March 2020; Estimated Recovery: December 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Valued Customer Emergency Syringe Portfolio Update

Other
44.6 mEq/50 mL (7.5%; 0.9 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4916-34) Limited Supply Available. Next Delivery: July 2020; Estimated Recovery: December 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Valued Customer Emergency Syringe Portfolio Update

Other
50 mEq/50 mL (8.4%; 1 mEq/mL); Single Dose Glass Fliptop Vial (NDC 0409-6625-02) Available Other
50 mEq/50 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-6637-34) Limited Supply Available. Next Delivery: March 2020; Estimated Recovery: December 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages


Dear Valued Customer Emergency Syringe Portfolio Update
Other
Pediatric; 10 mEq/10 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4900-34) Limited Supply Available. Next Delivery: March 2020; Estimated Recovery: December 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Dear Valued Customer Emergency Syringe Portfolio Update

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English